Related references
Note: Only part of the references are listed.DNA repair protein RAD51 enhances the CRISPR/Cas9-mediated knock-in efficiency in brain neurons
Taiga Kurihara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Ibalizumab: A Review in Multidrug-Resistant HIV-1 Infection
Hannah A. Blair
DRUGS (2020)
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
Susan Swindells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Kathryn E. Stephenson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Curing HIV: Seeking to Target and Clear Persistent Infection
David M. Margolis et al.
CELL (2020)
The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
Lillian B. Cohn et al.
CELL HOST & MICROBE (2020)
TRIM5α self-assembly and compartmentalization of the HIV-1 viral capsid
Alvin Yu et al.
NATURE COMMUNICATIONS (2020)
Measuring the Success of HIV-1 Cure Strategies
Jordan Thomas et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors
Guoling Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)
Structural and mechanistic bases for a potent HIV-1 capsid inhibitor
Stephanie M. Bester et al.
SCIENCE (2020)
Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem Cells
Jens Verheyen et al.
CLINICAL INFECTIOUS DISEASES (2019)
K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α
Sabrina Imam et al.
JOURNAL OF VIROLOGY (2019)
CRISPR-Cas based targeting of host and viral genes as an antiviral strategy
Lulia Koujah et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications
Kutubuddin A. Molla et al.
TRENDS IN BIOTECHNOLOGY (2019)
Nature and prevalence of adverse drug reaction of antiretroviral medications in Halibet National Referral Hospital: a retrospective study
Lidya Hagos et al.
BMC PHARMACOLOGY & TOXICOLOGY (2019)
Restriction of HIV-1 and other retroviruses by TRIM5
Barbie K. Ganser-Pornillos et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Strategies for inducing effective neutralizing antibody responses against HIV-1
Ivan del Moral-Sanchez et al.
EXPERT REVIEW OF VACCINES (2019)
Rhesus monkey TRIM5 alpha protein SPRY domain contributes to AP-1 activation
Lei Na et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency
Marella D. Canny et al.
NATURE BIOTECHNOLOGY (2018)
Eradication of HIV from Tissue Reservoirs: Challenges for the Cure
Rebecca Rose et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1
Caroline Dufour et al.
PLOS ONE (2018)
InducingCCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+Cell Line and Primary CD4+Cells by CRISPR-Cas9 Genome-Editing Technology
Chunxia Qi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
'Cold shock' increases the frequency of homology directed repair gene editing in induced pluripotent stem cells
Q. Guo et al.
SCIENTIFIC REPORTS (2018)
HIV-1 capsids from B27/B57(+) elite controllers escape Mx2 but are targeted by TRIM5 alpha, leading to the induction of an antiviral state
Natacha Merindol et al.
PLOS PATHOGENS (2018)
Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1
Marta Colomer-Lluch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Mechanisms of precise genome editing using oligonucleotide donors
Yinan Kan et al.
GENOME RESEARCH (2017)
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
Lei Xu et al.
MOLECULAR THERAPY (2017)
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
Thomas Gaj et al.
NUCLEIC ACIDS RESEARCH (2017)
Improved life expectancy of people living with HIV: who is left behind?
Ingrid T. Katz et al.
LANCET HIV (2017)
TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization
Edward M. Campbell et al.
JOURNAL OF VIROLOGY (2016)
Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets
Carla M. S. Ribeiro et al.
NATURE (2016)
The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion
Nasser Masroori et al.
RETROVIROLOGY (2016)
Characterisation of assembly and ubiquitylation by the RBCC motif of Trim5α
Jeremy R. Keown et al.
SCIENTIFIC REPORTS (2016)
A putative SUMO interacting motif in the B30.2/SPRY domain of rhesus macaque TRIM5 alpha important for NF-kappa B/AP-1 signaling and HIV-1 restriction
Marie-Edith Nepveu-Traversy et al.
HELIYON (2016)
Restriction Factors in HIV-1 Disease Progression
Natacha Merindol et al.
CURRENT HIV RESEARCH (2015)
TRIM5α requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription
Adam J. Fletcher et al.
EMBO JOURNAL (2015)
Preclinical Assessment of Mutant Human TRIM5α as an Anti-HIV-1 Transgene
Ulrike Jung et al.
HUMAN GENE THERAPY (2015)
CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus
HyunJun Kang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
TRIMmunity: The Roles of the TRIM E3-Ubiquitin Ligase Family in Innate Antiviral Immunity
Ricardo Rajsbaum et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation
Lambros Kordelas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The conserved sumoylation consensus site in TRIM5α modulates its immune activation functions
Marie-Edith Nepveu-Traversy et al.
VIRUS RESEARCH (2014)
Quality of life in chronic HIV infection
Anton Pozniak
LANCET HIV (2014)
Pressure from TRIM5α Contributes to Control of HIV-1 Replication by Individuals Expressing Protective HLA-B Alleles
Clemence Granier et al.
JOURNAL OF VIROLOGY (2013)
The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import
Maxime Veillette et al.
RETROVIROLOGY (2013)
A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen
Quang Toan Pham et al.
VIRUS RESEARCH (2013)
Fates of Retroviral Core Components during Unrestricted and TRIM5-Restricted Infection
Sebla B. Kutluay et al.
PLOS PATHOGENS (2013)
RING Domain Mutations Uncouple TRIM5α Restriction of HIV-1 from Inhibition of Reverse Transcription and Acceleration of Uncoating
Amanda Roa et al.
JOURNAL OF VIROLOGY (2012)
Generation of an HIV-1-Resistant Immune System with CD34+ Hematopoietic Stem Cells Transduced with a Triple-Combination Anti-HIV Lentiviral Vector
Jon E. Walker et al.
JOURNAL OF VIROLOGY (2012)
Recent Insights into the Mechanism and Consequences of TRIM5α Retroviral Restriction
Jaya Sastri et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
Kristina Allers et al.
BLOOD (2011)
Determinants of the Higher Order Association of the Restriction Factor TRIM5β and Other Tripartite Motif (TRIM) Proteins
Xing Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Modulation of TRIM5α Activity in Human Cells by Alternatively Spliced TRIM5 Isoforms
Emilie Battivelli et al.
JOURNAL OF VIROLOGY (2011)
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Thomas Pertel et al.
NATURE (2011)
Hexagonal assembly of a restricting TRIM5α protein
Barbie K. Ganser-Pornillos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Interferon-stimulated genes and their antiviral effector functions
John W. Schoggins et al.
CURRENT OPINION IN VIROLOGY (2011)
Generation of human TRIM5α mutants with high HIV-1 restriction activity
Q. T. Pham et al.
GENE THERAPY (2010)
TRIM5α Disrupts the Structure of Assembled HIV-1 Capsid Complexes In Vitro
Lesa R. Black et al.
JOURNAL OF VIROLOGY (2010)
Murine double minute 2 as a modulator of retroviral restrictions mediated by TRIM5α
Marine Malbec et al.
VIROLOGY (2010)
Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5α
Edward M. Campbell et al.
JOURNAL OF CELL BIOLOGY (2008)
Rhesus macaque TRIM5 Alleles have divergent antiretroviral specificities
Sam J. Wilson et al.
JOURNAL OF VIROLOGY (2008)
Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities
Laetitia Carthagena et al.
RETROVIROLOGY (2008)
Proteasomal degradation of TRIM5α during retrovirus restriction
Christopher James Rold et al.
PLOS PATHOGENS (2008)
Both TRIM5α and TRIMCyp have only weak antiviral activity in canine D17 cells
Julie Berube et al.
RETROVIROLOGY (2007)
Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins
Jenny L. Anderson et al.
JOURNAL OF VIROLOGY (2006)
Removal of arginine 332 allows human TRIM5α to bind human immunodeficiency virus capsids and to restrict infection
Yuan Li et al.
JOURNAL OF VIROLOGY (2006)
Proteasome inhibitors uncouple rhesus TRIM5α restriction of HIV-1 reverse transcription and infection
Xiaolu Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5α restriction factor
M Stremlau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Retroviral restriction factors Fv1 and TRIM5α act independently and can compete for incoming virus before reverse transcription
LD Passerini et al.
JOURNAL OF VIROLOGY (2006)
Cyclophilin A is required for TRIM5α-mediated resistance to HIV-1 in old world monkey cells
L Berthoux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human tripartite motif 5α domains responsible for retrovirus restriction activity and specificity
D Perez-Caballero et al.
JOURNAL OF VIROLOGY (2005)
Disruption of human TRIM5α antiviral activity by nonhuman primate orthologues
L Berthoux et al.
JOURNAL OF VIROLOGY (2005)
Retrovirus restriction by TRIM5α variants from old world and new world primates
B Song et al.
JOURNAL OF VIROLOGY (2005)
Species-specific variation in the B30.2(SPRY) domain of TRIM5α determines the potency of human immunodeficiency virus restriction
M Stremlau et al.
JOURNAL OF VIROLOGY (2005)
Positive selection of primate TRIM5α identifies a critical species-specific retroviral restriction domain
SL Sawyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A single amino acid change in the SPRY domain of human Trim5α leads to HIV-1 restriction
MW Yap et al.
CURRENT BIOLOGY (2005)
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
M Stremlau et al.
NATURE (2004)
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α
T Hatziioannou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression
JB Angel et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Share Paper
